IP Verse

Fred Hutchinson Cancer Research Center patent opposition analysis

CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Latest patents of Fred Hutchinson Cancer Research Center opposed by its competitors

Explore Fred Hutchinson Cancer Research Center's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 7, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3688157
Apr 27, 2022High Efficiency Targeted In Situ Genome-Wide Profiling1
EP3636778
Jan 12, 2022Agents For Use In Treating Facioscapulohumeral Dystrophy (Fshd)2
EP3247808
May 5, 2021Point-Of-Care And/Or Portable Platform For Gene Therapy2
EP3363901
Dec 30, 2020Compositions And Methods For Accurately Identifying Mutations3
EP2689010
Nov 18, 2020Method And Compositions For Cellular Immunotherapy1
EP2884999
Nov 4, 2020Method And Compositions For Cellular Immunotherapy1
EP3192880
Oct 9, 2019Nucleic Acid Agents For Use In Treating Facioscapulohumeral Dystrophy (Fshd)2
EP2814959
Jan 17, 2018Compositions And Methods For Accurately Identifying Mutations1

Top competitors of Fred Hutchinson Cancer Research Center

List of top competitors of Fred Hutchinson Cancer Research Center based on patent oppositions.